These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 18178927)

  • 1. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
    Bishop Hubbard H
    Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding newborn screening system issues with emphasis on cystic fibrosis screening.
    Therrell BL; Lloyd-Puryear MA; Mann MY
    J Pediatr; 2005 Sep; 147(3 Suppl):S6-10. PubMed ID: 16202785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions.
    Wilfond BS; Parad RB; Fost N
    J Pediatr; 2005 Sep; 147(3 Suppl):S109-13. PubMed ID: 16202773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health explores expanding newborn screening for cystic fibrosis, congenital adrenal hyperplasia, and medium-chain acyl coenzyme A dehydrogenase deficiency (MCAD).
    Rhoades E; King P
    J Okla State Med Assoc; 2001 Apr; 94(4):129-32. PubMed ID: 11392180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening: current status.
    Arn PH
    Health Aff (Millwood); 2007; 26(2):559-66. PubMed ID: 17339686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded newborn screening for genetic and metabolic disorders: modeling costs and outcomes.
    Hubbard HB
    Nurs Econ; 2007; 25(6):345-52. PubMed ID: 18240836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical, legal and social issues in newborn screening in the United States.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():52-8. PubMed ID: 15906695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
    Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
    Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded newborn screening: information and resources for the family physician.
    Waisbren SE
    Am Fam Physician; 2008 Apr; 77(7):987-94. PubMed ID: 18441864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States.
    Wilfond BS; Gollust SE
    J Pediatr; 2005 May; 146(5):668-74. PubMed ID: 15870672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.
    Comeau AM; Accurso FJ; White TB; Campbell PW; Hoffman G; Parad RB; Wilfond BS; Rosenfeld M; Sontag MK; Massie J; Farrell PM; O'Sullivan BP;
    Pediatrics; 2007 Feb; 119(2):e495-518. PubMed ID: 17272609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACOG Committee Opinion No. 393, December 2007. Newborn screening.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2007 Dec; 110(6):1497-500. PubMed ID: 18055755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inborn errors of metabolism and expanded newborn screening: review and update.
    Mak CM; Lee HC; Chan AY; Lam CW
    Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Talking with parents before newborn screening.
    Clayton EW
    J Pediatr; 2005 Sep; 147(3 Suppl):S26-9. PubMed ID: 16202778
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommended newborn screening policy change for the NICU infant.
    Balk KG
    Policy Polit Nurs Pract; 2007 Aug; 8(3):210-9. PubMed ID: 18178928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up data collection and use in state newborn screening programs.
    Hoff T; Ayoob M; Therrell BL
    Arch Pediatr Adolesc Med; 2007 Oct; 161(10):994-1000. PubMed ID: 17909144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Every child is priceless: debating effective newborn screening policy.
    Howell RR
    Hastings Cent Rep; 2009; 39(1):4-6; author reply 7-8. PubMed ID: 19213181
    [No Abstract]   [Full Text] [Related]  

  • 20. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.